康复新液入榜2020“中国医药•品牌榜”

2020-12-16 MedSci原创 MedSci原创

从药理学角度分析,康复新液富含多元醇类和多肽(表面细胞生长因子 EGF),能促迸表皮细胞生长和肉芽组织增生,改善局部血液循环,促进创面坏死组织脱落,加速创面修复。

      12月8日-11日,“2020全国医药经济信息发布会暨米房会年会”在广州举行,会议期间,2020“中国医药·品牌榜”正式对外发布。好医生康复新液荣登医院终端2020“中国医药·品牌榜”。

      2020“中国医药·品牌榜”分为“医院终端”、“基层终端”、“零售终端”和“锐榜”四个榜单。其中“医院终端”、“基层终端”、“零售终端”系根据“三大终端六大市场”终端监测数据显示的近三年产品在三个终端的销售金额和增长率,严格筛选入围各品类的药品品牌。

 

 

       作为能有效对人体黏膜修复治疗的无菌溶液剂,好医生集团生产的康复新液能在医生、药师与患者与群体中都有着良好的口碑。

       从药理学角度分析,康复新液富含多元醇类和多肽(表面细胞生长因子 EGF),能促迸表皮细胞生长和肉芽组织增生,改善局部血液循环,促进创面坏死组织脱落,加速创面修复。康复新液还含有粘糖氨酸,能增强巨噬细胞和 NK 细胞(natural killer cell)的吞噬能力,分泌类白细胞介素、干扰素、白三烯等物质,消除炎症水肿。临床观察表明该药有抗炎、消除炎性水肿的作用,可提高人体免疫功能,促进新生肉芽组织生长,迅速修复溃疡面,缩短伤口愈合时间。

      在肠胃病的治疗中,康复新液主动修复胃肠道黏膜。与大多数胃药不同,康复新液治疗胃部疾病从黏膜修复的方向出发,避免了长期反复发作的风险。例如在应用于胃溃疡的治疗中时,康复新液显示出的一个突出的优点为对组织的修复效果非常好。根据临床研究数据来看,胃溃疡的愈合不仅仅是修复缺失的黏膜,而且还要促成新的黏膜的生长,即重建黏膜下结构。从这一点来看,康复新液应用于胃溃疡的治疗中具有很强的针对性。康复新液的主要成分中含有大量的神经肽、氨基酸和表皮生长因子,这些活性物质能够有效促进胃黏膜中氨基己糖、前列腺素 E2 的含量增加,使氨基己糖、前列腺素 E2 分别起到保护胃黏膜、抑制胃酸分泌的作用,从而促进胃黏膜的修复,达到治疗目的。

      现代研究证实,康复新液通过抑制蛋白质及 RNA 的合成,达到抑菌抗感染的目的,使局部炎性反应减轻,渗出减少,从而促进创面愈合,且有对皮肤的刺激性小,渗透力强的特点。临床医疗数据验证了好医生集团生产的康复新液溶液剂具有消除炎症水肿、改善创面微循环、促进创面坏死组织脱落、促进肉芽组织生长、加速机体病损组织修复及抗炎的作用。

      好医生集团康复新液上市二十余年,已得到全国4000多家二甲及以上的医院和上万名临床专家的认可并处方使用,已成为10万家基层医疗单位的常备药品,得到广大患者的信赖。

      好医生集团始终坚守制药行业的“良心工业”本质,坚持“做好人,制好药”的企业理念,以严格的质量把控,致力于创新药物研发、高品质药品制造,为中国中医药产业的发展打造“金字招牌”。

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2079784, encodeId=a15720e978420, content=<a href='/topic/show?id=0e9421e61cb' target=_blank style='color:#2F92EE;'>#中国医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21761, encryptionId=0e9421e61cb, topicName=中国医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=zhangpaul93, createdTime=Tue Jul 20 17:00:59 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032022, encodeId=2b4f203202295, content=<a href='/topic/show?id=de0e4943257' target=_blank style='color:#2F92EE;'>#康复新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49432, encryptionId=de0e4943257, topicName=康复新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Fri Sep 03 22:00:59 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410091, encodeId=d7c61410091ae, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Dec 18 08:00:59 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908985, encodeId=409890898544, content=棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/3e1b73035bda42b4bc8db6b7a8fff978/5e03e09c932146729251f4e715282fa7.jpg, createdBy=26405427258, createdName=郭襄, createdTime=Thu Dec 17 23:12:27 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908794, encodeId=fb08908e94fd, content=好医生棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201216/acc2e79e3d994937861d94277f3d24b8/1a3c32dcdcc04ef8bcb0e505743f6c57.jpg, createdBy=73805409111, createdName=ms9000000194445124, createdTime=Thu Dec 17 09:42:09 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908708, encodeId=b83f908e0807, content=👍👍👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/18/75e5cf1dd2ba3c163cd6a2ba8b38e8cb.jpg, createdBy=092a5179619, createdName=cj小金金, createdTime=Wed Dec 16 21:44:43 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908706, encodeId=3cc8908e06fd, content=坚持质量, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a1b1464595, createdName=49752403, createdTime=Wed Dec 16 21:42:45 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908664, encodeId=8834908664a4, content=坚持品质, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43282639804, createdName=471796824, createdTime=Wed Dec 16 19:41:22 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908663, encodeId=be959086639e, content=😀, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210618/f4d42c7d6bf1474b9de89c32fd3dd3ae/276d9ad9d441404580b205ef3f68b5c7.jpg, createdBy=89095439818, createdName=ms3000001743104125, createdTime=Wed Dec 16 19:18:17 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908644, encodeId=82ce90864466, content=好药会有好的发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb45125889, createdName=146465bem06暂无昵称, createdTime=Wed Dec 16 18:34:33 CST 2020, time=2020-12-16, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2079784, encodeId=a15720e978420, content=<a href='/topic/show?id=0e9421e61cb' target=_blank style='color:#2F92EE;'>#中国医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21761, encryptionId=0e9421e61cb, topicName=中国医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=zhangpaul93, createdTime=Tue Jul 20 17:00:59 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032022, encodeId=2b4f203202295, content=<a href='/topic/show?id=de0e4943257' target=_blank style='color:#2F92EE;'>#康复新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49432, encryptionId=de0e4943257, topicName=康复新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Fri Sep 03 22:00:59 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410091, encodeId=d7c61410091ae, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Dec 18 08:00:59 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908985, encodeId=409890898544, content=棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/3e1b73035bda42b4bc8db6b7a8fff978/5e03e09c932146729251f4e715282fa7.jpg, createdBy=26405427258, createdName=郭襄, createdTime=Thu Dec 17 23:12:27 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908794, encodeId=fb08908e94fd, content=好医生棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201216/acc2e79e3d994937861d94277f3d24b8/1a3c32dcdcc04ef8bcb0e505743f6c57.jpg, createdBy=73805409111, createdName=ms9000000194445124, createdTime=Thu Dec 17 09:42:09 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908708, encodeId=b83f908e0807, content=👍👍👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/18/75e5cf1dd2ba3c163cd6a2ba8b38e8cb.jpg, createdBy=092a5179619, createdName=cj小金金, createdTime=Wed Dec 16 21:44:43 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908706, encodeId=3cc8908e06fd, content=坚持质量, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a1b1464595, createdName=49752403, createdTime=Wed Dec 16 21:42:45 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908664, encodeId=8834908664a4, content=坚持品质, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43282639804, createdName=471796824, createdTime=Wed Dec 16 19:41:22 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908663, encodeId=be959086639e, content=😀, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210618/f4d42c7d6bf1474b9de89c32fd3dd3ae/276d9ad9d441404580b205ef3f68b5c7.jpg, createdBy=89095439818, createdName=ms3000001743104125, createdTime=Wed Dec 16 19:18:17 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908644, encodeId=82ce90864466, content=好药会有好的发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb45125889, createdName=146465bem06暂无昵称, createdTime=Wed Dec 16 18:34:33 CST 2020, time=2020-12-16, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2079784, encodeId=a15720e978420, content=<a href='/topic/show?id=0e9421e61cb' target=_blank style='color:#2F92EE;'>#中国医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21761, encryptionId=0e9421e61cb, topicName=中国医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=zhangpaul93, createdTime=Tue Jul 20 17:00:59 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032022, encodeId=2b4f203202295, content=<a href='/topic/show?id=de0e4943257' target=_blank style='color:#2F92EE;'>#康复新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49432, encryptionId=de0e4943257, topicName=康复新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Fri Sep 03 22:00:59 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410091, encodeId=d7c61410091ae, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Dec 18 08:00:59 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908985, encodeId=409890898544, content=棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/3e1b73035bda42b4bc8db6b7a8fff978/5e03e09c932146729251f4e715282fa7.jpg, createdBy=26405427258, createdName=郭襄, createdTime=Thu Dec 17 23:12:27 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908794, encodeId=fb08908e94fd, content=好医生棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201216/acc2e79e3d994937861d94277f3d24b8/1a3c32dcdcc04ef8bcb0e505743f6c57.jpg, createdBy=73805409111, createdName=ms9000000194445124, createdTime=Thu Dec 17 09:42:09 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908708, encodeId=b83f908e0807, content=👍👍👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/18/75e5cf1dd2ba3c163cd6a2ba8b38e8cb.jpg, createdBy=092a5179619, createdName=cj小金金, createdTime=Wed Dec 16 21:44:43 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908706, encodeId=3cc8908e06fd, content=坚持质量, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a1b1464595, createdName=49752403, createdTime=Wed Dec 16 21:42:45 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908664, encodeId=8834908664a4, content=坚持品质, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43282639804, createdName=471796824, createdTime=Wed Dec 16 19:41:22 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908663, encodeId=be959086639e, content=😀, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210618/f4d42c7d6bf1474b9de89c32fd3dd3ae/276d9ad9d441404580b205ef3f68b5c7.jpg, createdBy=89095439818, createdName=ms3000001743104125, createdTime=Wed Dec 16 19:18:17 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908644, encodeId=82ce90864466, content=好药会有好的发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb45125889, createdName=146465bem06暂无昵称, createdTime=Wed Dec 16 18:34:33 CST 2020, time=2020-12-16, status=1, ipAttribution=)]
    2020-12-18 cathymary
  4. [GetPortalCommentsPageByObjectIdResponse(id=2079784, encodeId=a15720e978420, content=<a href='/topic/show?id=0e9421e61cb' target=_blank style='color:#2F92EE;'>#中国医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21761, encryptionId=0e9421e61cb, topicName=中国医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=zhangpaul93, createdTime=Tue Jul 20 17:00:59 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032022, encodeId=2b4f203202295, content=<a href='/topic/show?id=de0e4943257' target=_blank style='color:#2F92EE;'>#康复新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49432, encryptionId=de0e4943257, topicName=康复新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Fri Sep 03 22:00:59 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410091, encodeId=d7c61410091ae, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Dec 18 08:00:59 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908985, encodeId=409890898544, content=棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/3e1b73035bda42b4bc8db6b7a8fff978/5e03e09c932146729251f4e715282fa7.jpg, createdBy=26405427258, createdName=郭襄, createdTime=Thu Dec 17 23:12:27 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908794, encodeId=fb08908e94fd, content=好医生棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201216/acc2e79e3d994937861d94277f3d24b8/1a3c32dcdcc04ef8bcb0e505743f6c57.jpg, createdBy=73805409111, createdName=ms9000000194445124, createdTime=Thu Dec 17 09:42:09 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908708, encodeId=b83f908e0807, content=👍👍👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/18/75e5cf1dd2ba3c163cd6a2ba8b38e8cb.jpg, createdBy=092a5179619, createdName=cj小金金, createdTime=Wed Dec 16 21:44:43 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908706, encodeId=3cc8908e06fd, content=坚持质量, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a1b1464595, createdName=49752403, createdTime=Wed Dec 16 21:42:45 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908664, encodeId=8834908664a4, content=坚持品质, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43282639804, createdName=471796824, createdTime=Wed Dec 16 19:41:22 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908663, encodeId=be959086639e, content=😀, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210618/f4d42c7d6bf1474b9de89c32fd3dd3ae/276d9ad9d441404580b205ef3f68b5c7.jpg, createdBy=89095439818, createdName=ms3000001743104125, createdTime=Wed Dec 16 19:18:17 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908644, encodeId=82ce90864466, content=好药会有好的发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb45125889, createdName=146465bem06暂无昵称, createdTime=Wed Dec 16 18:34:33 CST 2020, time=2020-12-16, status=1, ipAttribution=)]
    2020-12-17 郭襄

    棒!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2079784, encodeId=a15720e978420, content=<a href='/topic/show?id=0e9421e61cb' target=_blank style='color:#2F92EE;'>#中国医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21761, encryptionId=0e9421e61cb, topicName=中国医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=zhangpaul93, createdTime=Tue Jul 20 17:00:59 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032022, encodeId=2b4f203202295, content=<a href='/topic/show?id=de0e4943257' target=_blank style='color:#2F92EE;'>#康复新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49432, encryptionId=de0e4943257, topicName=康复新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Fri Sep 03 22:00:59 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410091, encodeId=d7c61410091ae, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Dec 18 08:00:59 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908985, encodeId=409890898544, content=棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/3e1b73035bda42b4bc8db6b7a8fff978/5e03e09c932146729251f4e715282fa7.jpg, createdBy=26405427258, createdName=郭襄, createdTime=Thu Dec 17 23:12:27 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908794, encodeId=fb08908e94fd, content=好医生棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201216/acc2e79e3d994937861d94277f3d24b8/1a3c32dcdcc04ef8bcb0e505743f6c57.jpg, createdBy=73805409111, createdName=ms9000000194445124, createdTime=Thu Dec 17 09:42:09 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908708, encodeId=b83f908e0807, content=👍👍👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/18/75e5cf1dd2ba3c163cd6a2ba8b38e8cb.jpg, createdBy=092a5179619, createdName=cj小金金, createdTime=Wed Dec 16 21:44:43 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908706, encodeId=3cc8908e06fd, content=坚持质量, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a1b1464595, createdName=49752403, createdTime=Wed Dec 16 21:42:45 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908664, encodeId=8834908664a4, content=坚持品质, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43282639804, createdName=471796824, createdTime=Wed Dec 16 19:41:22 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908663, encodeId=be959086639e, content=😀, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210618/f4d42c7d6bf1474b9de89c32fd3dd3ae/276d9ad9d441404580b205ef3f68b5c7.jpg, createdBy=89095439818, createdName=ms3000001743104125, createdTime=Wed Dec 16 19:18:17 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908644, encodeId=82ce90864466, content=好药会有好的发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb45125889, createdName=146465bem06暂无昵称, createdTime=Wed Dec 16 18:34:33 CST 2020, time=2020-12-16, status=1, ipAttribution=)]
    2020-12-17 ms9000000194445124

    好医生棒

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2079784, encodeId=a15720e978420, content=<a href='/topic/show?id=0e9421e61cb' target=_blank style='color:#2F92EE;'>#中国医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21761, encryptionId=0e9421e61cb, topicName=中国医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=zhangpaul93, createdTime=Tue Jul 20 17:00:59 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032022, encodeId=2b4f203202295, content=<a href='/topic/show?id=de0e4943257' target=_blank style='color:#2F92EE;'>#康复新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49432, encryptionId=de0e4943257, topicName=康复新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Fri Sep 03 22:00:59 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410091, encodeId=d7c61410091ae, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Dec 18 08:00:59 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908985, encodeId=409890898544, content=棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/3e1b73035bda42b4bc8db6b7a8fff978/5e03e09c932146729251f4e715282fa7.jpg, createdBy=26405427258, createdName=郭襄, createdTime=Thu Dec 17 23:12:27 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908794, encodeId=fb08908e94fd, content=好医生棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201216/acc2e79e3d994937861d94277f3d24b8/1a3c32dcdcc04ef8bcb0e505743f6c57.jpg, createdBy=73805409111, createdName=ms9000000194445124, createdTime=Thu Dec 17 09:42:09 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908708, encodeId=b83f908e0807, content=👍👍👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/18/75e5cf1dd2ba3c163cd6a2ba8b38e8cb.jpg, createdBy=092a5179619, createdName=cj小金金, createdTime=Wed Dec 16 21:44:43 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908706, encodeId=3cc8908e06fd, content=坚持质量, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a1b1464595, createdName=49752403, createdTime=Wed Dec 16 21:42:45 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908664, encodeId=8834908664a4, content=坚持品质, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43282639804, createdName=471796824, createdTime=Wed Dec 16 19:41:22 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908663, encodeId=be959086639e, content=😀, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210618/f4d42c7d6bf1474b9de89c32fd3dd3ae/276d9ad9d441404580b205ef3f68b5c7.jpg, createdBy=89095439818, createdName=ms3000001743104125, createdTime=Wed Dec 16 19:18:17 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908644, encodeId=82ce90864466, content=好药会有好的发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb45125889, createdName=146465bem06暂无昵称, createdTime=Wed Dec 16 18:34:33 CST 2020, time=2020-12-16, status=1, ipAttribution=)]
    2020-12-16 cj小金金

    👍👍👍

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2079784, encodeId=a15720e978420, content=<a href='/topic/show?id=0e9421e61cb' target=_blank style='color:#2F92EE;'>#中国医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21761, encryptionId=0e9421e61cb, topicName=中国医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=zhangpaul93, createdTime=Tue Jul 20 17:00:59 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032022, encodeId=2b4f203202295, content=<a href='/topic/show?id=de0e4943257' target=_blank style='color:#2F92EE;'>#康复新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49432, encryptionId=de0e4943257, topicName=康复新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Fri Sep 03 22:00:59 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410091, encodeId=d7c61410091ae, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Dec 18 08:00:59 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908985, encodeId=409890898544, content=棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/3e1b73035bda42b4bc8db6b7a8fff978/5e03e09c932146729251f4e715282fa7.jpg, createdBy=26405427258, createdName=郭襄, createdTime=Thu Dec 17 23:12:27 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908794, encodeId=fb08908e94fd, content=好医生棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201216/acc2e79e3d994937861d94277f3d24b8/1a3c32dcdcc04ef8bcb0e505743f6c57.jpg, createdBy=73805409111, createdName=ms9000000194445124, createdTime=Thu Dec 17 09:42:09 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908708, encodeId=b83f908e0807, content=👍👍👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/18/75e5cf1dd2ba3c163cd6a2ba8b38e8cb.jpg, createdBy=092a5179619, createdName=cj小金金, createdTime=Wed Dec 16 21:44:43 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908706, encodeId=3cc8908e06fd, content=坚持质量, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a1b1464595, createdName=49752403, createdTime=Wed Dec 16 21:42:45 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908664, encodeId=8834908664a4, content=坚持品质, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43282639804, createdName=471796824, createdTime=Wed Dec 16 19:41:22 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908663, encodeId=be959086639e, content=😀, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210618/f4d42c7d6bf1474b9de89c32fd3dd3ae/276d9ad9d441404580b205ef3f68b5c7.jpg, createdBy=89095439818, createdName=ms3000001743104125, createdTime=Wed Dec 16 19:18:17 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908644, encodeId=82ce90864466, content=好药会有好的发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb45125889, createdName=146465bem06暂无昵称, createdTime=Wed Dec 16 18:34:33 CST 2020, time=2020-12-16, status=1, ipAttribution=)]
    2020-12-16 49752403

    坚持质量

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2079784, encodeId=a15720e978420, content=<a href='/topic/show?id=0e9421e61cb' target=_blank style='color:#2F92EE;'>#中国医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21761, encryptionId=0e9421e61cb, topicName=中国医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=zhangpaul93, createdTime=Tue Jul 20 17:00:59 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032022, encodeId=2b4f203202295, content=<a href='/topic/show?id=de0e4943257' target=_blank style='color:#2F92EE;'>#康复新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49432, encryptionId=de0e4943257, topicName=康复新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Fri Sep 03 22:00:59 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410091, encodeId=d7c61410091ae, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Dec 18 08:00:59 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908985, encodeId=409890898544, content=棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/3e1b73035bda42b4bc8db6b7a8fff978/5e03e09c932146729251f4e715282fa7.jpg, createdBy=26405427258, createdName=郭襄, createdTime=Thu Dec 17 23:12:27 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908794, encodeId=fb08908e94fd, content=好医生棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201216/acc2e79e3d994937861d94277f3d24b8/1a3c32dcdcc04ef8bcb0e505743f6c57.jpg, createdBy=73805409111, createdName=ms9000000194445124, createdTime=Thu Dec 17 09:42:09 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908708, encodeId=b83f908e0807, content=👍👍👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/18/75e5cf1dd2ba3c163cd6a2ba8b38e8cb.jpg, createdBy=092a5179619, createdName=cj小金金, createdTime=Wed Dec 16 21:44:43 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908706, encodeId=3cc8908e06fd, content=坚持质量, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a1b1464595, createdName=49752403, createdTime=Wed Dec 16 21:42:45 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908664, encodeId=8834908664a4, content=坚持品质, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43282639804, createdName=471796824, createdTime=Wed Dec 16 19:41:22 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908663, encodeId=be959086639e, content=😀, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210618/f4d42c7d6bf1474b9de89c32fd3dd3ae/276d9ad9d441404580b205ef3f68b5c7.jpg, createdBy=89095439818, createdName=ms3000001743104125, createdTime=Wed Dec 16 19:18:17 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908644, encodeId=82ce90864466, content=好药会有好的发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb45125889, createdName=146465bem06暂无昵称, createdTime=Wed Dec 16 18:34:33 CST 2020, time=2020-12-16, status=1, ipAttribution=)]
    2020-12-16 471796824

    坚持品质

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2079784, encodeId=a15720e978420, content=<a href='/topic/show?id=0e9421e61cb' target=_blank style='color:#2F92EE;'>#中国医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21761, encryptionId=0e9421e61cb, topicName=中国医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=zhangpaul93, createdTime=Tue Jul 20 17:00:59 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032022, encodeId=2b4f203202295, content=<a href='/topic/show?id=de0e4943257' target=_blank style='color:#2F92EE;'>#康复新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49432, encryptionId=de0e4943257, topicName=康复新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Fri Sep 03 22:00:59 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410091, encodeId=d7c61410091ae, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Dec 18 08:00:59 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908985, encodeId=409890898544, content=棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/3e1b73035bda42b4bc8db6b7a8fff978/5e03e09c932146729251f4e715282fa7.jpg, createdBy=26405427258, createdName=郭襄, createdTime=Thu Dec 17 23:12:27 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908794, encodeId=fb08908e94fd, content=好医生棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201216/acc2e79e3d994937861d94277f3d24b8/1a3c32dcdcc04ef8bcb0e505743f6c57.jpg, createdBy=73805409111, createdName=ms9000000194445124, createdTime=Thu Dec 17 09:42:09 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908708, encodeId=b83f908e0807, content=👍👍👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/18/75e5cf1dd2ba3c163cd6a2ba8b38e8cb.jpg, createdBy=092a5179619, createdName=cj小金金, createdTime=Wed Dec 16 21:44:43 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908706, encodeId=3cc8908e06fd, content=坚持质量, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a1b1464595, createdName=49752403, createdTime=Wed Dec 16 21:42:45 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908664, encodeId=8834908664a4, content=坚持品质, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43282639804, createdName=471796824, createdTime=Wed Dec 16 19:41:22 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908663, encodeId=be959086639e, content=😀, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210618/f4d42c7d6bf1474b9de89c32fd3dd3ae/276d9ad9d441404580b205ef3f68b5c7.jpg, createdBy=89095439818, createdName=ms3000001743104125, createdTime=Wed Dec 16 19:18:17 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908644, encodeId=82ce90864466, content=好药会有好的发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb45125889, createdName=146465bem06暂无昵称, createdTime=Wed Dec 16 18:34:33 CST 2020, time=2020-12-16, status=1, ipAttribution=)]
    2020-12-16 ms3000001743104125

    😀

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2079784, encodeId=a15720e978420, content=<a href='/topic/show?id=0e9421e61cb' target=_blank style='color:#2F92EE;'>#中国医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21761, encryptionId=0e9421e61cb, topicName=中国医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=zhangpaul93, createdTime=Tue Jul 20 17:00:59 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032022, encodeId=2b4f203202295, content=<a href='/topic/show?id=de0e4943257' target=_blank style='color:#2F92EE;'>#康复新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49432, encryptionId=de0e4943257, topicName=康复新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Fri Sep 03 22:00:59 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410091, encodeId=d7c61410091ae, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Dec 18 08:00:59 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908985, encodeId=409890898544, content=棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/3e1b73035bda42b4bc8db6b7a8fff978/5e03e09c932146729251f4e715282fa7.jpg, createdBy=26405427258, createdName=郭襄, createdTime=Thu Dec 17 23:12:27 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908794, encodeId=fb08908e94fd, content=好医生棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201216/acc2e79e3d994937861d94277f3d24b8/1a3c32dcdcc04ef8bcb0e505743f6c57.jpg, createdBy=73805409111, createdName=ms9000000194445124, createdTime=Thu Dec 17 09:42:09 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908708, encodeId=b83f908e0807, content=👍👍👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/18/75e5cf1dd2ba3c163cd6a2ba8b38e8cb.jpg, createdBy=092a5179619, createdName=cj小金金, createdTime=Wed Dec 16 21:44:43 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908706, encodeId=3cc8908e06fd, content=坚持质量, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a1b1464595, createdName=49752403, createdTime=Wed Dec 16 21:42:45 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908664, encodeId=8834908664a4, content=坚持品质, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43282639804, createdName=471796824, createdTime=Wed Dec 16 19:41:22 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908663, encodeId=be959086639e, content=😀, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210618/f4d42c7d6bf1474b9de89c32fd3dd3ae/276d9ad9d441404580b205ef3f68b5c7.jpg, createdBy=89095439818, createdName=ms3000001743104125, createdTime=Wed Dec 16 19:18:17 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908644, encodeId=82ce90864466, content=好药会有好的发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb45125889, createdName=146465bem06暂无昵称, createdTime=Wed Dec 16 18:34:33 CST 2020, time=2020-12-16, status=1, ipAttribution=)]
    2020-12-16 146465bem06暂无昵称

    好药会有好的发展

    0